Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PINC vs INVA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PINC
Premier, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$2.34B
5Y Perf.-18.8%
INVA
Innoviva, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.93B
5Y Perf.+30.3%

PINC vs INVA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PINC logoPINC
INVA logoINVA
IndustryMedical - Healthcare Information ServicesBiotechnology
Market Cap$2.34B$1.93B
Revenue (TTM)$1.00B$424M
Net Income (TTM)$-24M$504M
Gross Margin72.6%76.2%
Operating Margin-0.0%14.8%
Forward P/E20.8x11.9x
Total Debt$282M$269M
Cash & Equiv.$84M$551M

PINC vs INVALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PINC
INVA
StockMay 20Nov 25Return
Premier, Inc. (PINC)10081.2-18.8%
Innoviva, Inc. (INVA)100130.3+30.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: PINC vs INVA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: INVA leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Premier, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
PINC
Premier, Inc.
The Income Pick

PINC is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 0.07, yield 3.0%
  • Lower volatility, beta 0.07, Low D/E 18.4%, current ratio 0.64x
  • Beta 0.07, yield 3.0%, current ratio 0.64x
Best for: income & stability and sleep-well-at-night
INVA
Innoviva, Inc.
The Growth Play

INVA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 18.5%, EPS growth 8.2%, 3Y rev CAGR 8.7%
  • 94.9% 10Y total return vs PINC's -4.6%
  • 18.5% revenue growth vs PINC's -10.9%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthINVA logoINVA18.5% revenue growth vs PINC's -10.9%
ValueINVA logoINVALower P/E (11.9x vs 20.8x)
Quality / MarginsINVA logoINVA118.9% margin vs PINC's -2.4%
Stability / SafetyPINC logoPINCBeta 0.07 vs INVA's 0.13, lower leverage
DividendsPINC logoPINC3.0% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)PINC logoPINC+24.0% vs INVA's +21.7%
Efficiency (ROA)INVA logoINVA32.4% ROA vs PINC's -0.8%, ROIC 14.2% vs 0.0%

PINC vs INVA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PINCPremier, Inc.
FY 2025
Administrative Fees
100.0%$556M
INVAInnoviva, Inc.
FY 2025
Royalty
57.5%$236M
Product
41.8%$172M
License And Other Revenue
0.7%$3M

PINC vs INVA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINVALAGGINGPINC

Income & Cash Flow (Last 12 Months)

INVA leads this category, winning 6 of 6 comparable metrics.

PINC is the larger business by revenue, generating $1.0B annually — 2.4x INVA's $424M. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to PINC's -2.4%. On growth, INVA holds the edge at +10.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPINC logoPINCPremier, Inc.INVA logoINVAInnoviva, Inc.
RevenueTrailing 12 months$1.0B$424M
EBITDAEarnings before interest/tax$118M$86M
Net IncomeAfter-tax profit-$24M$504M
Free Cash FlowCash after capex$265M$181M
Gross MarginGross profit ÷ Revenue+72.6%+76.2%
Operating MarginEBIT ÷ Revenue-0.0%+14.8%
Net MarginNet income ÷ Revenue-2.4%+118.9%
FCF MarginFCF ÷ Revenue+26.4%+42.8%
Rev. Growth (YoY)Latest quarter vs prior year-3.3%+10.6%
EPS Growth (YoY)Latest quarter vs prior year-70.0%+4.0%
INVA leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

INVA leads this category, winning 4 of 6 comparable metrics.

At 6.9x trailing earnings, INVA trades at a 95% valuation discount to PINC's 128.5x P/E. On an enterprise value basis, INVA's 8.1x EV/EBITDA is more attractive than PINC's 21.3x.

MetricPINC logoPINCPremier, Inc.INVA logoINVAInnoviva, Inc.
Market CapShares × price$2.3B$1.9B
Enterprise ValueMkt cap + debt − cash$2.5B$1.7B
Trailing P/EPrice ÷ TTM EPS128.45x6.91x
Forward P/EPrice ÷ next-FY EPS est.20.79x11.91x
PEG RatioP/E ÷ EPS growth rate0.67x
EV / EBITDAEnterprise value multiple21.35x8.10x
Price / SalesMarket cap ÷ Revenue2.31x4.55x
Price / BookPrice ÷ Book value/share1.70x1.65x
Price / FCFMarket cap ÷ FCF7.33x9.88x
INVA leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

INVA leads this category, winning 8 of 9 comparable metrics.

INVA delivers a 46.5% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-2 for PINC. PINC carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to INVA's 0.23x. On the Piotroski fundamental quality scale (0–9), INVA scores 5/9 vs PINC's 4/9, reflecting solid financial health.

MetricPINC logoPINCPremier, Inc.INVA logoINVAInnoviva, Inc.
ROE (TTM)Return on equity-1.6%+46.5%
ROA (TTM)Return on assets-0.8%+32.4%
ROICReturn on invested capital+0.0%+14.2%
ROCEReturn on capital employed+0.0%+12.4%
Piotroski ScoreFundamental quality 0–945
Debt / EquityFinancial leverage0.18x0.23x
Net DebtTotal debt minus cash$198M-$282M
Cash & Equiv.Liquid assets$84M$551M
Total DebtShort + long-term debt$282M$269M
Interest CoverageEBIT ÷ Interest expense1.13x63.45x
INVA leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

INVA leads this category, winning 4 of 5 comparable metrics.

A $10,000 investment in INVA five years ago would be worth $19,437 today (with dividends reinvested), compared to $9,080 for PINC. Over the past 12 months, PINC leads with a +24.0% total return vs INVA's +21.7%. The 3-year compound annual growth rate (CAGR) favors INVA at 25.0% vs PINC's 4.7% — a key indicator of consistent wealth creation.

MetricPINC logoPINCPremier, Inc.INVA logoINVAInnoviva, Inc.
YTD ReturnYear-to-date+14.7%
1-Year ReturnPast 12 months+24.0%+21.7%
3-Year ReturnCumulative with dividends+14.8%+95.2%
5-Year ReturnCumulative with dividends-9.2%+94.4%
10-Year ReturnCumulative with dividends-4.6%+94.9%
CAGR (3Y)Annualised 3-year return+4.7%+25.0%
INVA leads this category, winning 4 of 5 comparable metrics.

Risk & Volatility

PINC leads this category, winning 2 of 2 comparable metrics.

PINC is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than INVA's 0.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs INVA's 90.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPINC logoPINCPremier, Inc.INVA logoINVAInnoviva, Inc.
Beta (5Y)Sensitivity to S&P 5000.07x0.13x
52-Week HighHighest price in past year$28.79$25.15
52-Week LowLowest price in past year$20.62$16.52
% of 52W HighCurrent price vs 52-week peak+98.2%+90.7%
RSI (14)Momentum oscillator 0–10065.039.9
Avg Volume (50D)Average daily shares traded0621K
PINC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PINC leads this category, winning 1 of 1 comparable metric.

Wall Street rates PINC as "Hold" and INVA as "Buy". Consensus price targets imply 65.2% upside for INVA (target: $38) vs -0.0% for PINC (target: $28). PINC is the only dividend payer here at 2.98% yield — a key consideration for income-focused portfolios.

MetricPINC logoPINCPremier, Inc.INVA logoINVAInnoviva, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$28.25$37.67
# AnalystsCovering analysts3110
Dividend YieldAnnual dividend ÷ price+3.0%
Dividend StreakConsecutive years of raises10
Dividend / ShareAnnual DPS$0.84
Buyback YieldShare repurchases ÷ mkt cap+17.1%+0.2%
PINC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

INVA leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). PINC leads in 2 (Risk & Volatility, Analyst Outlook).

Best OverallInnoviva, Inc. (INVA)Leads 4 of 6 categories
Loading custom metrics...

PINC vs INVA: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is PINC or INVA a better buy right now?

For growth investors, Innoviva, Inc.

(INVA) is the stronger pick with 18. 5% revenue growth year-over-year, versus -10. 9% for Premier, Inc. (PINC). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Innoviva, Inc. (INVA) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PINC or INVA?

On trailing P/E, Innoviva, Inc.

(INVA) is the cheapest at 6. 9x versus Premier, Inc. at 128. 5x. On forward P/E, Innoviva, Inc. is actually cheaper at 11. 9x.

03

Which is the better long-term investment — PINC or INVA?

Over the past 5 years, Innoviva, Inc.

(INVA) delivered a total return of +94. 4%, compared to -9. 2% for Premier, Inc. (PINC). Over 10 years, the gap is even starker: INVA returned +94. 9% versus PINC's -4. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PINC or INVA?

By beta (market sensitivity over 5 years), Premier, Inc.

(PINC) is the lower-risk stock at 0. 07β versus Innoviva, Inc. 's 0. 13β — meaning INVA is approximately 78% more volatile than PINC relative to the S&P 500. On balance sheet safety, Premier, Inc. (PINC) carries a lower debt/equity ratio of 18% versus 23% for Innoviva, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PINC or INVA?

By revenue growth (latest reported year), Innoviva, Inc.

(INVA) is pulling ahead at 18. 5% versus -10. 9% for Premier, Inc. (PINC). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -78. 8% for Premier, Inc.. Over a 3-year CAGR, INVA leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PINC or INVA?

Innoviva, Inc.

(INVA) is the more profitable company, earning 63. 8% net margin versus 2. 0% for Premier, Inc. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus 0. 1% for PINC. At the gross margin level — before operating expenses — PINC leads at 73. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PINC or INVA more undervalued right now?

On forward earnings alone, Innoviva, Inc.

(INVA) trades at 11. 9x forward P/E versus 20. 8x for Premier, Inc. — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INVA: 65. 2% to $37. 67.

08

Which pays a better dividend — PINC or INVA?

In this comparison, PINC (3.

0% yield) pays a dividend. INVA does not pay a meaningful dividend and should not be held primarily for income.

09

Is PINC or INVA better for a retirement portfolio?

For long-horizon retirement investors, Premier, Inc.

(PINC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 07), 3. 0% yield). Both have compounded well over 10 years (PINC: -4. 6%, INVA: +94. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PINC and INVA?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: PINC is a small-cap quality compounder stock; INVA is a small-cap high-growth stock. PINC pays a dividend while INVA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PINC

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 43%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

INVA

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 71%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PINC and INVA on the metrics below

Revenue Growth>
%
(PINC: -3.3% · INVA: 10.6%)
P/E Ratio<
x
(PINC: 128.5x · INVA: 6.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.